<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1408245768
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1985
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        URALYT-U GRANULES
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        POTASSIUM SODIUM HYDROGEN CITRATE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        2.4
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Granules
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        280
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        1
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        52.1
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Rottapharm|Madaus Group" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Rottapharm|Madaus Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 530]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Salehiya Trading Co.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Viatris Healthcare GmbH
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        A12BA02 
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Uralyt-U </strong>is an alkali citrate for the treatment of urolithiasis.</p><p>Indications:</p><p>- dissolution of uric acid stones;</p><p>- metaphylaxis (prevention of recidivation) of calcium containing</p><p>stones and uric acid stones as well as mixed stones of</p><p>calcium oxalate / uric acid or calcium oxalate / calcium phosphate.</p><p>Note: The product administration should be part of a general</p><p>metaphylaxis (i.e. diet, increased fluid uptake etc.)</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>You should not take Uralyt-U if you suffer from acute or chronic</p><p>renal failure, medically prescribed low sodium diet, suffer from</p><p>metabolic alkalosis, excessive blood potassium levels (hyperkalemia)</p><p>or suffer from chronic urinary tract infections with</p><p>urea-splitting bacteria.</p><p>&nbsp;</p><p><strong>Do not take Uralyt-U</strong></p><p>- if you are allergic to potassium sodium hydrogen citrate, yellow</p><p>orange S (E 110) or any of the other ingredients of this</p><p>medicine (listed in section 6).</p><p>&nbsp;</p><p><strong>Warnings and precautions</strong></p><p>Talk to your doctor or pharmacist before taking Uralyt-U</p><p>- Before starting therapy all circumstances/malconditions that</p><p>may be in favour of urinary calculi should be excluded. The</p><p>same is true if there exists a specific therapy (adenoma of</p><p>parathyroid glands, malignoma with generation of uric acid</p><p>calculi etc.).</p><p>- Before taking the first dose the serum electrolytes should be</p><p>determined and renal function should be monitored. Furthermore,</p><p>the acid base status should be checked when renal</p><p>tubular acidosis (RTA) is suspected.</p><p>- Especially in the elderly or in patients with impaired renal function</p><p>or at simultaneous therapy with some medicinal products</p><p>against high blood pressure (e.g. aldosterone antagonists, AT</p><p>II antagonists, potassium-saving diuretics, ACE-inhibitors) or</p><p>against chronic pain (non-steroidal anti-inflammatory drugs</p><p>and peripheral analgesics), it should be considered that the</p><p>maximum recommended daily dose is 11,25 g granulate (4.5</p><p>levels measuring spoonfuls). This is equivalent to 1.86 g potassium</p><p>and 1.09 g sodium, i.e. 47.5 mmol potassium and</p><p>47.5 mmol sodium. Interaction with these medicinal products</p><p>can lead to hyperkalemia.</p><p>- Be cautious with the use of <strong>Uralyt-U </strong>in patients with severe</p><p>disturbances of liver function.</p><p>- Yellow orange S (E 110) may cause allergic reactions. This</p><p>medicinal product contains yellow orange S (E 110) and may</p><p>cause allergic reactions especially in people who are most</p><p>sensitive against this excipient.</p><p><strong>Children and adolescents</strong></p><p>The treatment of children less than 12 years of age is not recommended</p><p>as there is not enough clinical experience for this</p><p>age group.</p><p>&nbsp;</p><p><strong>Other medicines and Uralyt-U</strong></p><p>Any increase in extracellular potassium concentration weakens</p><p>the effect of cardiac glycosides, while any decrease favours</p><p>the onset of heart rhythm disorders under treatment with cardiac</p><p>glycosides. Some medicinal products against high blood</p><p>pressure (e.g. aldosterone antagonists, AT II antagonists, potassium-</p><p>saving diuretics, ACE-inhibitors) or against chronical</p><p>pain (non-steroidal anti-inflammatory drugs and peripheral analgesics)</p><p>reduce the potassium excretion in urine. Remember</p><p>that 10 g of <strong>Uralyt-U </strong>(average daily dose) contain 1.72 g or 44</p><p>mmol potassium.</p><p>When prescribing a low-sodium diet, please remember that 10 g</p><p>of <strong>Uralyt-U </strong>(average daily dose) contain 1.0 g or 44 mmol sodium</p><p>(equivalent to 2.6 g sodium chloride).</p><p>Drugs containing citrate given at the same time as drugs containing</p><p>aluminium (e.g. against heartburn) can cause an increase in</p><p>aluminium absorption; if such drugs have to be taken, an interval of</p><p>at least 2 hours must be allowed between taking each kind of drug.</p><p><em>Please note that these data may apply also to medicines, which</em></p><p><em>have just recently been used.</em></p><p>Tell your doctor or pharmacist if you are taking/using, have recently</p><p>taken/used or might take/use any other medicines.</p><p>&nbsp;</p><p><strong>Pregnancy and breast-feeding</strong></p><p>There are not enough clinical data about the use of <strong>Uralyt-U </strong>in</p><p>pregnant or lactating women. Experimental studies in animals</p><p>did not reveal any hints of harmful effects.</p><p>If you are pregnant or breast feeding, please ask your doctor</p><p>before taking <strong>Uralyt-U</strong>.</p><p>&nbsp;</p><p><strong>Driving and using machines</strong></p><p>There are no restrictions.</p><p>&nbsp;</p><p><strong>Important information about some of the ingredients of</strong></p><p><strong>Uralyt-U</strong></p><p>This drug contains the colouring agent yellow orange S (E 110 )</p><p>which may induce allergic reactions, including asthma, in a</p><p>sensitized person. Allergy is more often seen in people reacting</p><p>to 2-acetoxybenzoic acid (acetylsalicylic acid).</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take this medicine exactly as described in this leaflet or</p><p>as your doctor has told you. Check with your doctor or pharmacist</p><p>if you are not sure.</p><p><em>Further, unless your doctor has prescribed Uralyt-U otherwise,</em></p><p><em>the following instructions apply. Please follow the directions for</em></p><p><em>use because otherwise </em><strong><em>Uralyt-U </em></strong><em>cannot act properly!</em></p><p><em>&nbsp;</em></p><p><strong>a) To dissolve and prevent recidivation of uric acid stones:</strong></p><p>The recommended dose is:</p><p>Take 4 levels measuring spoonfuls (= 10 g granules) daily divided</p><p>into three doses, after meals.</p><p>Take 1 level measuring spoonful every morning, 1 level measuring</p><p>spoonful at midday, and 2 levels measuring spoonfuls</p><p>every evening after meals.</p><p>The pH of the fresh urine should be within the following range:</p><p>Uric acid stones: pH 6.2 &ndash; pH 6.8.</p><p>If the pH reading is below the recommended range, the daily</p><p>dose should be increased by half a measuring spoonful in the</p><p>evening. If the pH reading is above the recommended range,</p><p>the daily dose should be reduced by half a measuring spoonful</p><p>in the evening.</p><p>The correct dose has been found, when the pH of the fresh</p><p>urine, before taking the dose of <strong>Uralyt-U</strong>, is within the recommended</p><p>range.</p><p>For the prevention of recidivation of uric acid stones, regular</p><p>checks of the urine pH are advisable.</p><p>&nbsp;</p><p><strong>b) To prevent the recidivation of calcium containing stones:</strong></p><p>The recommended dose is:</p><p>The daily dose should be 2 - 3 levels measuring spoonfuls (= 5 g</p><p>- 7.5 g granules) and should be taken as a single dose in the</p><p>evening. If the pH reading is too low, 3 - 4.5 levels measuring</p><p>spoonfuls (= 7.5 - 11.25 g granules) should be taken in 2 - 3</p><p>doses divided over the day, after meals.</p><p>A urine pH reading of 7.0 should be aimed at. The pH should</p><p>not fall below 6.2 and should not rise above 7.4.</p><p>Citrate levels and/or urine pH readings should be regularly</p><p>checked and the individual dose (see above) adjusted accordingly.</p><p>&nbsp;</p><p><strong>Method of administration</strong></p><p>The granules should be dissolved in a glass of water, which</p><p>then should be drunk.</p><p><em>Measurement of urine pH:</em></p><p>Immediately before taking each dose, take a test strip of the</p><p>indicator paper supplied with this pack and moisten with fresh</p><p>urine. Now compare the colour of the moist strip with the colour</p><p>chart and read off the pH printed below the matching colour.</p><p>This pH reading and the number of measuring spoonfuls of</p><p>granules that you have taken are to be entered in the control</p><p>calendar. - You should take the control calendar with you every</p><p>time you visit the doctor.</p><p>&nbsp;</p><p><strong>Duration of administration</strong></p><p>Your doctor will determine the duration of treatment. In case of</p><p>persisting complaints you should see your doctor.</p><p>If you have the impression that the effect of <strong>Uralyt-U </strong>is too</p><p>strong or too weak, talk to your doctor or pharmacist.</p><p>&nbsp;</p><p><strong>If you take more Uralyt-U than you should</strong></p><p>Provided that renal function is adequate, no adverse effects</p><p>on metabolic or physiological parameters are to be expected</p><p>even when <strong>Uralyt-U </strong>has been taken in doses larger than those</p><p>recommended.</p><p>Overdose can lead to Hyperkalemia (Potassium-Plasma level</p><p>&gt;5 mmol/l), especially in patients with simultaneous acidosis</p><p>or renal failure.</p><p>Any overdose can be recognised at any time by checking the</p><p>urine pH and can be corrected by reducing the dose.</p><p>A doctor should be consulted if necessary.</p><p>If you have any further questions on the use of this medicine,</p><p>ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines this medicine can cause side effects, although</p><p>not everybody gets them.</p><p>Side effects&rsquo; rating was based on the following frequency data:</p><p>Very common more than 1 of 10 treated patients</p><p>Common 1 to 10 of 100 treated patients</p><p>Uncommon 1 to 10 of 1,000 treated patients</p><p>Rare 1 to 10 of 10,000 treated patients</p><p>Very rare less than 1 treated patient of 10,000</p><p>Not known cannot be estimated from the available data</p><p>&nbsp;</p><p><strong>Possible side effects:</strong></p><p>Gastrointestinal disorders:</p><p>Mild gastric or abdominal pain is common. In rare cases mild</p><p>diarrhoea or nausea may occur.</p><p>Other possible side effects</p><p>Yellow orange S (E110) may provoke allergic reactions</p><p>If any of the side effects gets serious, or if you notice any side</p><p>effects not listed in this leaflet, please tell your doctor, health</p><p>care or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not store above 30&deg;C.</p><p>Keep this medicine out of the sight and reach of children.</p><p>Do not use this medicine after the expiry date which is stated</p><p>on the tin and label.</p><p>Medicines should not be disposed of via wastewater or household</p><p>waste. Ask your pharmacist how to dispose of medicines</p><p>no longer required. These measures will help to protect the</p><p>environment.</p><p>&nbsp;</p><p><strong>Storage conditions:</strong></p><p>Once the solution has been prepared it should be drunk immediately.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>- The active substance is potassium sodium hydrogen citrate</p><p>One measuring spoonful (2.5 g) contains:</p><p>Potassium sodium hydrogen citrate (6:6:3:5) 2.4 g</p><p>- The other ingredients are:</p><p>lemon oil (aroma) and yellow orange S (E 110) (colouring</p><p>agent).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                Original packs with 280 g (300 g) with pale orange granulate.
The packs contain a measuring spoon and indicator paper.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Marketing Authorisation Holder</strong></p><p>MEDA Pharma GmbH &amp; Co. KG</p><p>Benzstrasse 1</p><p>61352 Bad Homburg, Germany</p><p>Tel.: (06172) 888-01</p><p>Fax: (06172) 888-27 40</p><p>&nbsp;</p><p><strong>Manufacturer</strong></p><p><strong>&nbsp;</strong></p><p><strong>Bulk Manufacturer</strong></p><p>Martin Bauer GmbH &amp; Co. KG</p><p>Birkenweg 3</p><p>63801 Kleinostheim</p><p>Germany</p><p>&nbsp;</p><p><strong>Filling, Packaging and batch releasing site</strong></p><p>Madaus GmbH - 51101 Cologne</p><p><strong>Site address</strong></p><p>Madaus GmbH</p><p>L&uuml;tticher Stra&szlig;e 5</p><p>53842 Troisdorf</p><p>Germany</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                02/2021
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>يوراليت-يو سيترات قلوية لعلاج الحصى البولي</p><p>&nbsp;</p><p>دواعي الاستعمال:</p><p>&nbsp;&nbsp;-إذابة حصوات حمض اليوريك</p><p>&nbsp;&nbsp;- الوقاية من (منع معاودة) الحصوات المحتوية على الكالسيوم وحصوات حمض اليوريك</p><p>وكذلك الحصوات المختلطة لأكسالات الكالسيوم/حمض اليوريك أو أكسالات الكالسيوم</p><p>فوسفات الكالسيوم/</p><p>ملاحظة: يجب أن يمثل إعطاء المنتج أحد أجزاء عملية الوقاية العامة (كاتباع نظام</p><p>غذائي، زيادة تناول السوائل، إلخ)</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;</p><p>نظاماً غذائياً منخفض الصوديوم وصفه لك الطبيب أو تعاني من القلاء الأيضي أو الارتفاع</p><p>الشديد في مستويات البوتاسيوم في الدم (فرط بوتاسيوم الدم) أو تعاني من التهاب المسالك</p><p>البولية المزمن بسبب البكتيريا الشاطرة للبولينا</p><p><strong>لا تتناول يوراليت-يو</strong></p><p>إذا كنت تعاني من حساسية من بوتاسيوم صوديوم هيدروجين سيترات أو المادة الملونة (أصفر</p><p>.) أو أي من مكونات الدواء الأخرى (المذكورة في القسم 6 )E برتقالي) ( تصنيف 110</p><p><strong>التحذيرات والاحتياطات</strong></p><p>تحدث إلى طبيبك أو الصيدلي قبل تناول يوراليت-يو</p><p>- يجب استبعاد جميع الظروف/الحالات المرضية التي قد تحفز تكوين الحصوات البولية</p><p>قبل بدء العلاج. وينطبق الأمر نفسه إذا كنت تخضع لعلاج معين (ورم الغدة الدرقية</p><p>الحميد، الورم الخبيث مع تكون حصوات حمض اليوريك إلخ)</p><p>قبل تناول أول جرعة يجب تحديد مستوى الأملاح في مصل الدم ومراقبة وظائف الكلى-</p><p>علاوة على ذلك، يجب فحص وضع الأحماض والقواعد عند الاشتباه في الإصابة</p><p>بأمراض الحماض الكلوي النبيبي.</p><p>&nbsp;بالنسبة لكبار السن أو المرضى المصابين باختلال وظائف الكلى أو يتلقون في نفس&nbsp; -</p><p>الوقت بعض المنتجات الدوائية لعلاج ارتفاع ضغط الدم (مثل مضادات الألدوستيرون</p><p>ومدرات البول الحافظة للبوتاسيوم ومثبطات الإنزيم II ومضادات مستقبلات أنجيوتنسين</p><p>المحول للأنجيوتنسين) أو الآلام المزمنة (مضادات الالتهابات اللاستيرويدية والمسكنات</p><p>المحيطية) بصفة خاصة، يجب مراعاة ألا تزيد الجرعة اليومية الموصى بها من الحبيبات</p><p>&nbsp;جم (مقدار 4.5 ملعقة قياسية). وهذا يعادل 1.86 جم من البوتاسيوم و 1.09 11.25</p><p>جم من الصوديوم، أي 47.5 ملليمول من البوتاسيوم و 47.5 ملليمول من الصوديوم.</p><p>فالتفاعل مع هذه المنتجات الدوائية يؤدي إلى فرط بوتاسيوم الدم</p><p>&nbsp;كن حذراً عند استخدام يوراليت-يو مع المرضى المصابين باضطرابات شديدة في&nbsp; -</p><p>وظائف الكبد</p><p>رد فعل تحسسي. ويحتوي )E - - قد تسبب المادة الملونة (أصفر برتقالي)(تصنيف 110</p><p>وقد يسبب رد )E هذا المنتج الدوائي على المادة الملونة (أصفر برتقالي)(تصنيف 110</p><p>فعل تحسسي ولا سيما لدى الأشخاص الأكثر حساسية لهذا السواغ</p><p>&nbsp;</p><p><strong>الأطفال والمراهقون</strong></p><p>لا ينصح بمعالجة الأطفال دون سن 12 عاماً لعدم وجود تجارب سريرية كافية لهذه الفئة العمرية</p><p>&nbsp;</p><p><strong>الأدوية الأخرى ويوراليت-يو</strong></p><p>أي زيادة في تركيز البوتاسيوم خارج الخلية تؤدي إلى إضعاف تأثير غليكوسيدات القلب،</p><p>في حين يؤدي أي خفض إلى تعزيز بداية ظهور اضطرابات ضربات القلب عند العلاج</p><p>بغليكوسيدات القلب. وتؤدي بعض المنتجات الدوائية المستخدمة في علاج ارتفاع ضغط</p><p>ومدرات البول II الدم (مثل مضادات الألدوستيرون ومضادات مستقبلات أنجيوتنسين</p><p>الحافظة للبوتاسيوم ومثبطات الإنزيم المحول للأنجيوتنسين) أو الآلام المزمنة (مضادات</p><p>الالتهابات اللاستيرويدية والمسكنات المحيطية) إلى تقليل إفراز البوتاسيوم في البول. تذكر</p><p>أن 10 جم من يو ا رليت-يو (متوسط الجرعة اليومية) تحتوي على 1.72 جم أو 44</p><p>ملليمول من البوتاسيوم</p><p>عند وصف نظام غذائي منخفض الصوديوم، يرجى تذكر أن 10 جم من يوراليت-يو</p><p>&nbsp;متوسط الجرعة اليومية تحتوي على 1.0 جم أو 44 ملليمول من الصوديوم (أي ما يعادل</p><p>&nbsp;جم من كلوريد الصوديوم)&nbsp; 2.6 &nbsp;</p><p>يمكن أن يؤدي تعاطي العقاقير المحتوية على السيترات مع العقاقير المحتوية على</p><p>الألومنيوم ( لعلاج الحرقة المعدية على سبيل المثال) إلى زيادة امتصاص الألومنيوم، إ و</p><p>كان من الضروري تناول هذه العقاقير فيجب الانتظار لمدة ساعتين على الأقل بعد تناول</p><p>كل نوع من العقارين</p><p>يرجى ملاحظة أن هذه البيانات ربما تنطبق أيضاً على الأدوية التي تم استخدامها مؤخرًا</p><p>أخبر طبيبك أو الصيدلي إذا كنت تتناول/تستخدم -أو بدأت تتناول/تستخدم مؤخرًا أو ربما</p><p>ستتناول/ستستخدم- أي أدوية أخرى</p><p>&nbsp;</p><p><strong>الحمل والإرضاع</strong></p><p>ليس هناك ما يكفي من البيانات السريرية حول استخدام السيدات الحوامل أو المرضعات</p><p>ليوراليت-يو. ولم تُظهِر الدراسات التجريبية التي أجريت على الحيوانات أي تلميحات</p><p>لوجود آثار ضارة</p><p>إذا كنتِ حاملاً أو ترضعين رضاعة طبيعية، يرجى استشارة طبيبك قبل تناول يوراليت-يو</p><p>&nbsp;</p><p><strong>القيادة واستخدام الآلات</strong></p><p>لا توجد قيود</p><p>&nbsp;</p><p><strong>معلومات هامة حول بعض مكونات يوراليت-يو</strong></p><p>التي قد تسبب )E يحتوي هذا العقار على المادة الملونة (أصفر برتقالي)(تصنيف 110</p><p>تفاعلات تحسسية، بما في ذلك الربو، لدى الأشخاص المصابين بالحساسية. وتظهر</p><p>الحساسية في كثير من الأحيان لدى الأشخاص الذين يستجيبون لتأثير حمض أسيتيل</p><p>الساليسيليك (أسبرين)</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>تناول هذا الدواء دائماً كما هو مبين في هذه النشرة تماماً أو حسب وصفة طبيبك.</p><p>استشر طبيبك أو الصيدلي إن كنت غير متأكد</p><p>وكذلك، إذا لم يصف لك الطبيب يوراليت-يو على نحو مختلف، يجب اتباع التعليمات التالية</p><p>&nbsp;يرجى اتباع إرشادات الاستخدام &nbsp;وألا لن يعمل يوراليت-يو بشكل صحيح!</p><p><strong>أ) لإذابة حصوات حمض اليوريك ومنع معاودة تكونها :</strong></p><p>الجرعة الموصى بها:</p><p>تناول مقدار 4 ملاعق قياسية (= 10 جم من الحبيبات) يومياً موزعة على ثلاث جرعات</p><p>بعد الوجبات</p><p>تناول مقدار ملعقة قياسية واحدة كل صباح ومقدار ملعقة قياسية واحدة في منتصف النهار</p><p>ومقدار 2 ملعقة قياسية كل مساء بعد الوجبات</p><p>يجب أن تقع درجة حموضة البول الجديد ضمن المستوى التالي:</p><p>.6.8 &ndash; حصوات حمض اليوريك: درجة الحموضة 6.2</p><p>إذا كانت قراءة درجة الحموضة أقل من المستوى الموصى به، يجب زيادة الجرعة اليومية</p><p>بمقدار نصف ملعقة قياسية في المساء. إو اذا كانت قراءة درجة الحموضة أعلى من المستوى &nbsp;&nbsp;</p><p>الموصى به، يجب خفض الجرعة اليومية بمقدار نصف ملعقة قياسية في المساء</p><p>يتم التوصل إلى الجرعة الصحيحة، عندما تقع درجة حموضة البول الجديد قبل تناول جرعة</p><p>يوراليت-يو ضمن المدى الموصى به.</p><p>لمنع معاودة تكون حصوات حمض اليوريك، ينصح بإجراء فحوصات منتظمة لدرجة</p><p>حموضة البول</p><p><strong>ب) لمنع معاودة تكون الحصوات المحتوية على الكالسيوم</strong></p><p>الجرعة الموصى بها:</p><p>&nbsp;ملاعق قياسية (= 5 جم &ndash; 7.5 جم من 3- يجب أن تكون الجرعة اليومية بمقدار 2</p><p>الحبيبات) ويجب أن يتم تناولها كجرعة واحدة في المساء. إذا كانت قراءة درجة الحموضة</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11.25 &nbsp;&nbsp;منخفضة جداً، يجب تناول 3- 4.5 ملعقة قياسية (= 7.5 -</p><p>جم من الحبيبات) تؤخذ على جرعتين أو ثلاث جرعات مقسمة على مدار اليوم بعد الوجبات</p><p>يجب أن تكون قراءة درجة حموضة البول 7.0 . ويجب ألا تقل درجة الحموضة عن 6.2</p><p>. ولا تزيد عن 7.4</p><p>يجب فحص مستويات السيترات و/أو قراءات درجة حموضة البول بانتظام وتعديل الجرعة</p><p>المفردة (انظر أعلاه) وفقاً لذلك</p><p><strong>طريقة الاستخدام</strong></p><p>يجب إذابة الحبيبات في كوب من الماء وشربه في الحال</p><p>قياس درجة حموضة البول</p><p>قبل تناول كل جرعة مباشرة، خذ شريط اختبار من الورق المشعر الذي يأتي مع هذه العبوة</p><p>وبلله بالبول الجديد. والآن قارن لون الشريط المبلل بجدول الألوان واقرأ درجة الحموضة</p><p>المطبوعة أسفل اللون المطابق للون عينتك</p><p>وعليك إدخال قراءة درجة الحموضة هذه وعدد الملاعق القياسية التي تناولتها من الحبيبات</p><p>في تقويم المراقبة. - يجب أن تأخذ تقويم المراقبة معك كلما زرت الطبيب</p><p><strong>مدة الاستخدام</strong></p><p>سيحدد طبيبك مدة الاستخدام. وفي حال استمرار وجود شكوى يجب عليك مراجعة طبيبك.</p><p>إذا كان لديك انطباع بأن تأثير يوراليت-يو قوي جداً أو ضعيف جداً، تحدث إلى طبيبك</p><p>أو الصيدلي</p><p><strong>إذا تناولت كمية أكثر مما يجب من يوراليت-يو</strong></p><p>إذا كانت وظائف الكلى تعمل بشكل جيد، ليس من المتوقع ظهور آثار ضارة على عملية</p><p>التمثيل الغذائي والمؤشرات الفسيولوجية عند تناول يوراليت-يو بجرعات أكبر من تلك</p><p>الموصى بها</p><p>يمكن أن يؤدي تناول جرعات زائدة إلى الإصابة بفرط بوتاسيوم الدم (مستوى البوتاسيوم</p><p>في البلازما &nbsp;5 ملليمول/لتر)، ولا سيما لدى المرضى المصابين بالحماض أو الفشل الكلوي&lt;</p><p>في نفس الوقت</p><p>يمكن التعرف على أي جرعة زائدة في أي وقت من خلال فحص درجة حموضة البول</p><p>ويمكن تصحيحها بتقليل الجرعة</p><p>يجب استشارة طبيب إذا لزم الأمر</p><p>إذا كان لديك أي استفسارات أخرى حول استخدام هذا الدواء، استشر طبيبك أو الصيدلي</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>&nbsp;</p><p>أن يعاني منها الجميع</p><p>اعتمد تصنيف الآثار الجانبية على بيانات تكرار الحدوث التالية:</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&nbsp;</p><table dir="rtl" border="0" cellspacing="0" cellpadding="0" style="width:257px"><tbody><tr><td style="vertical-align:top"><p dir="RTL">شائعة جدا</p></td><td style="vertical-align:top"><p dir="RTL">أكثر من 1 من أصل 10 مرضى تم علاجهم بهذا الدواء</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">شائعة</p></td><td style="vertical-align:top"><p dir="RTL">1 إلى 10 من أصل 100 مريض تم علاجهم بهذا الدواء</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">غير شائعة</p></td><td style="vertical-align:top"><p dir="RTL">1 إلى 10 من أصل 1000 مريض تم علاجهم بهذا الدواء</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">نادرة</p></td><td style="vertical-align:top"><p dir="RTL">1 إلى 10 من أصل 10000 مريض تم علاجهم بهذا الدواء</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">نادرة جدا</p></td><td style="vertical-align:top"><p dir="RTL">أقل من 1 من أصل 10000 مريض تم علاجهم بهذا الدواء</p></td></tr><tr><td style="vertical-align:top"><p dir="RTL">غير معروفة</p></td><td style="vertical-align:top"><p dir="RTL">لا يمكن تحديد النسبة من البيانات المتوفرة</p></td></tr></tbody></table><p>&nbsp;</p><p><strong>الآثار الجانبية المحتملة: </strong></p><p>اضطرابات الجهاز الهضمي:</p><p>من الشائع حدوث ألم خفيف في المعدة أو البطن. في حالات نادرة قد يحدث إسهال</p><p>خفيف وغثيان</p><p>آثار جانبية أخرى محتملة</p><p>التفاعلات التحسسية. )E قد تثير المادة الملونة (أصفر برتقالي)(تصنيف 110</p><p>في حال أصبحت أي من الأعراض الجانبية متكررة أو واضحة أو إذا لاحظت أي أعراض</p><p>جانبية غير مذكورة في هذه النشرة، يرجى إخبار طبيبك أو الصيدلي</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>احفظ هذا الدواء بعيداً عن نظر ومتناول الأطفال.</p><p>لا تستخدم هذا الدواء بعد انتهاء تاريخ صلاحيته المذكور على العلبة والغلاف.</p><p>لا تقم بتخزينه في درجة حرارة أعلى من ٣٠ درجة مئوية.</p><p>لا تتخلص من أي دواء في ماء الصرف الصحي أو مع المخلفات المنزلية</p><p>. اسأل الصيدلي</p><p>عن كيفية التخلص من الأدوية التي لم تعد بحاجة إليها. ستساعد هذه الإجراءات في</p><p>الحفاظ على البيئة</p><p><strong>شروط التخزين: </strong></p><p>يجب شرب المحلول بعد تحضيره مباشرة</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>المادة الفعالة هي سيترات البوتاسيوم والصوديوم الهيدروجينية</p><p>تحتوي كل ملعقة قياسية ( 2.5 جم) على::</p><p>جم &nbsp;&nbsp;2.4 &nbsp;بوتاسيوم صوديوم هيدروجين سيترات (5:3:6:6 )</p><p>&nbsp;&nbsp;-المكونات الأخرى هي:</p><p>.)E زيت الليمون ( رائحة) والمادة الملونة (أصفر برتقالي)(تصنيف 110</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p>أصلية تحتوي على 280 جم ( 300 جم) من الحبيبات البرتقالية الباهتة.</p><p>حتوي العبوة على ملعقة قياسية وورق فحص مستوى الحموضة</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p><strong>&nbsp;المفوض بالتسويق</strong></p><p>ميدا للصناعات الدوائية ذات المسوؤلية المحدودة</p><p>1 بنزاسترس</p><p>&nbsp;باد هامبورغ، ألمانيا&nbsp; 61352</p><p>)06172( 888- هاتف: 01</p><p>)06172( 888- فاكس: 2740 &nbsp;</p><p><strong>المصنع</strong></p><p><strong>مصنع الحبيبات</strong></p><p>مارتن باور للصناعات ذات المسؤولية المحدودة</p><p>بيركن ويج 3</p><p>&nbsp; كلنيوستايم63801</p><p>المانيا</p><p><strong>التعبئه و التغليف و الفسح</strong></p><p>ماداوس ذات المسؤولية المحدودة - 51101 ، كولون</p><p>عنوان الموقع</p><p>ماداوس ذات المسؤولية المحدودة</p><p>لوتيشار سترابا 5</p><p>ترويسدورف&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 53842</p><p>ألمانيا</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            فبراير- 2021
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 Uralyt-U®
Granules for oral solution
Active substance: Potassium sodium hydrogen citrate (6:6:3:5)

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 Active substance:
Each measuring spoonful of 2.5 g of granules contains:
Potassium sodium hydrogen citrate (6:6:3:5): 2.4 g
For the full list of excipients, see section 6.1.

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 Granules
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>- For dissolution of uric acid stones</p><p>- For metaphylaxis (prevention of recurrent formation) of calcium stones and uric acid stones and/or mixed calcium oxalate and uric acid stones or mixed calcium oxalate and calcium phosphate stones.</p><p>NOTE:</p><p>This product should only be used as part of a general concept of metaphylaxis (e.g. diet, increased fluid uptake, etc.).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Posology</p><p><strong>a) Dissolution and metaphylaxis of uric acid stones</strong></p><p>In general, it is recommended to take 4 measuring spoonfuls (= 10 g of granules,equivalent to 88 mmol of alkali) daily, divided into three doses, after meals. One measuring spoonful shall be taken in the morning, 1 measuring spoonful at noon and 2 measuring spoonfuls in the evening.</p><p>The pH value of the freshly voided urine should be within the range of:</p><p>Uric acid stones: pH 6.2 &ndash; 6.8.</p><p>If the pH value is below the specified range, the daily dose should be increased by half a measuring spoonful of <strong>Uralyt-U</strong><strong>&reg; </strong>(11 mmol of alkali) in the evening. If the pH is above the specified range, the daily dose should be reduced by half a measuring spoonful (11 mmol of alkali) in the evening.</p><p>The correct dosage has been reached if the pH value of the freshly voided urine, measured before taking the dose of <strong>Uralyt-U</strong><strong>&reg;</strong>, is within the specified range.</p><p>For metaphylaxis of uric acid stones, regular checks of the urine pH levels are recommended.</p><p>&nbsp;</p><p><strong>b) Metaphylaxis of calcium-containing kidney stones:</strong></p><p>The recommended daily dose is 2-3 measuring spoonfuls (= 5-7.5 g of granules, equivalent to 44-66 mmol of alkali) and should be taken in a single dose in the evening.</p><p>If needed, i.e. if the measured pH value is too low, 3-4.5 measuring spoonfuls (= 7.5 g-11.25 g of granules, equivalent to 66 to 99 mmol of alkali) should be taken in 2-3 doses divided over the day, after meals.</p><p>A neutral pH value should be aimed at. The pH value should not be lower than 6.2 and should not exceed pH 7.4.</p><p>Citrate levels and/or urine pH values should be regularly checked and the individual dose (see above) be adjusted accordingly.</p><p>&nbsp;</p><p><strong>Method of administration:</strong></p><p>The granules shall be dissolved in a glass of water and drunk.</p><p>Measurement of the urine pH value:</p><p>Immediately before taking each dose, a test strip of the indicator paper provided in the pack should be wetted with freshly voided urine using the clamp also supplied in this pack.</p><p>&nbsp;</p><p>The colour of the wet test strip shall then be compared with the colour chart, and the pH value printed below the corresponding colour can be read off.</p><p>This pH reading as well as the number of measuring spoonfuls of granules taken should be noted in the control calendar. The patient shall bring along this calendar every time he/she visits the doctor.</p><p>&nbsp;</p><p><em>Paediatric population</em></p><p>No data are available.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 In the patient information leaflet it is pointed out to the patient that
Uralyt-U® should not be used in cases of:
- Impaired renal excretory function
- Metabolic alkalosis
- Hyperkalaemia
- Adynamia episodica hereditaria
- Chronic urinary tract infections with urea-splitting bacteria (danger of formation of struvit stones)
- Low sodium diet
- Hypersensitivity to potassium sodium hydrogen citrate, Yellow Orange S (E 110), or to any of the excipients.
Note:
The treatment of children less than 12 years of age is not recommended as there is insufficient clinical experience for this age group.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Before starting treatment, all circumstances or diseases which may be in favour of urinary stones and for which well-targeted therapy is available (such as adenoma of parathyroid glands, malignancy associated with uric acid stones etc.) should be ruled out.</p><p>The maximum recommended daily dose is 11.25 g of granules (4.5 measuring spoonfuls). This is equivalent to 1.86 g of potassium and 1.09 g of sodium, i.e. 47.5 mmol of potassium and 47.5 mmol of sodium. This should be considered in particular when treating the elderly and in case of concomitant therapy with potassium-saving diuretics, aldosterone antagonists, ACE inhibitors, angiotensin receptor antagonists, non-steroidal anti-inflammatory drugs or peripheral analgesics.</p><p>Interaction with these medicinal products can lead to hyperkalaemia.</p><p>Before taking the first dose, the serum electrolytes should be determined and renal function should be monitored. Moreover, the acid-base status should be checked when renal tubular acidosis (RTA) is suspected.</p><p>&nbsp;</p><p><strong>Uralyt-U</strong><strong>&reg; </strong>should be used with caution in patients with severely impaired liver function.</p><p>This medicinal product contains the colouring agent Yellow Orange S (E 110) which may induce allergic reactions including asthma in sensitized persons. Allergy is more often seen in people reacting to 2-acetoxybenzoic acid (acetylsalicylic acid).</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Any increase in extracellular potassium concentration will weaken the effect of cardiac glycosides, while any decrease will potentiate the arrhythmogenic effect of cardiac glycosides. Aldosterone antagonists, potassium-saving diuretics, ACE inhibitors, angiotensin receptor antagonists, non-steroidal anti-inflammatory drugs and peripheral analgesics reduce renal potassium excretion. Attention should be paid to the fact that 1.0 g of potassium sodium hydrogen citrate contains 0.172 g or 4.4 mmol of potassium.</p><p>&nbsp;</p><p>When prescribing a low sodium diet it should be remembered that 1.0 g of potassium sodium hydrogen citrate contains 0.1 g or 4.4 mmol of sodium (equivalent to 0.26 g of sodium chloride).</p><p>&nbsp;</p><p>Concomitant administration of substances containing citrate and aluminium can lead to increased aluminium absorption; if such medicines need to be taken, an interval of at least 2 hours must be allowed between taking each kind of product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>There is no adequate clinical data from the use of <strong>Uralyt-U</strong><strong>&reg; </strong>in pregnant women.</p><p>Experimental studies in animals did not indicate any teratogenic or embryotoxic effects.</p><p>As the active substance is a combination of physiologically occurring substances, <strong>Uralyt-U</strong><strong>&reg; </strong>may be used in pregnancy and lactation under the specified dose recommendations.</p><p>&nbsp;</p><p>No indications of harmful effects during pregnancy and lactation have been noted.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Uralyt-U</strong><strong>&reg; </strong>has no or negligible influence on the ability to drive or use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>The rating for side effects is based on the following frequency convention:</p><p>Very common &gt; 1/10</p><p>Common &gt; 1/100 - &lt; 1/10</p><p>Uncommon &gt; 1/1,000 - &lt; 1/100</p><p>Rare &gt; 1/10,000 - &lt; 1/1,000</p><p>Very rare &lt; 1/10,000</p><p>Not known Frequency cannot be estimated from the available data.</p><p>Gastrointestinal disorders:</p><p>Mild gastric or abdominal pain are common. In rare cases, mild diarrhoea and nausea may occur.</p><p>&nbsp;</p><p>Other possible undesirable effects:</p><p>Yellow Orange S (E 110) may provoke allergic reactions.</p><p>&nbsp;</p><p><strong>Reporting of suspected adverse reactions</strong></p><p>Reporting suspected adverse reactions after authorisation of the product is important.</p><p>It allows continued monitoring of the benefit/risk balance of the medicinal product.</p><p>Healthcare professionals are asked to report any suspected adverse reactions via</p><p>&nbsp;</p><p>Saudi Arabia:</p><p>The National Pharmacovigilance Centre (NPC):</p><p>Fax: +966-11-205-7662</p><p>SFDA Call Center: 19999</p><p>E-mail:npc.drug@sfda.gov.sa</p><p>Website: https://ade.sfda.gov.sa/</p><p>Other Countries:</p><p>Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Overdose can lead to hyperkalaemia (potassium-plasma level &gt;5 mmol/l), in particular in patients with simultaneous acidosis or renal failure.</p><p>Provided that renal function is adequate, there is no likelihood of any unwanted effects on normal metabolic physiological parameters, even after taking doses higher than those recommended, since the excretion of any base excess via the kidney provides a natural regulatory mechanism which ensures maintenance of the acid-base balance.</p><p>&nbsp;</p><p>It should be avoided that the specified urine pH range will be exceeded for several days, since considerably elevated pH values are related with an increased risk of phosphate crystallisation. On the other hand, the long-term establishment of a marked alkalotic metabolic state shall not be achieved. Inadvertent overdosage can be corrected at any time by reducing the dose; if necessary, appropriate measures for the treatment of metabolic alkalosis may be considered.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Pharmacotherapeutic group: Alkali citrates, agents for urolithiasis</p><p>ATC code: G04BC01</p><p>Salts of strong bases with weak acids are suitable for alkalinization (neutralization therapy), and the acid component is assumed to be metabolizable. The citrate ion from alkali citrates undergoes almost complete oxidative metabolic breakdown to CO2 or bicarbonate. The base excess resulting from the remaining alkali ions is eliminated via the kidneys and produces an increase in urine pH value.</p><p>Neutralisation or alkalinization of the urine can be achieved by oral administration of alkali citrates, the response being dose-dependent.</p><p>1 g of potassium sodium hydrogen citrate (8.8 mmol of alkali) causes the urine pH value to increase by 0.2&ndash;0.3 units. As a result, the dissociation rate increases and thus the solubility of uric acid. Litholysis of uric acid stones has been radiologically demonstrated.</p><p>Serum concentration of bicarbonate (negatively charged base excess) is the regulator of citrate excretion. Negatively charged base excess induces alkalosis via a shift in intracellular pH value.</p><p>&nbsp;</p><p>This leads to alkalosis-induced inhibition of renal tubular metabolism of citrate what results in reduced reabsorption of citrate and increased citrate excretion. At the same time, alkalosis has an influence on renal calcium flux by significantly reducing urinary calcium excretion.</p><p>Alkalisation of urine, increased excretion of citrate and reduced excretion of calcium lead to a decrease in the activity product of calcium oxalate, as citrate in weak alkalotic milieu forms stable complexes with calcium. Moreover, the citrate ion must be regarded as the most effective physiological inhibitor of calcium oxalate (and calcium phosphate) crystallisation and aggregation of these crystals.</p><p>&nbsp;</p><p>To assess the usefulness of urinary alkalisation in the following kinds of illness, data from systematic trials are lacking. Observations in single cases as well as theoretical considerations speak for a therapeutic effect:</p><p>- Cystinuria and cystine stone formation: Alkalisation of urine increases the solubility of cystine. However, urinary pH should arrive at values ranging between 7.5 and 8.5.</p><p>- Treatment with cytostatics: Alkalisation of urine in order to eliminate the rise in uric acid makes sense during a treatment with cytostatics. This is in line with the prophylaxis of uric acid stones, claimed as therapeutic indication. In addition, a protective effect of alkalotic urinary pH value is claimed because of reduced aggressivity of cytostatic metabolites (e.g. oxazaphosphorin cytostatics) and their increased solubility (e.g. methotrexate), respectively. For this purpose, urinary pH level</p><p>should be regulated to a value of 7.0 at least.</p><p>- Porphyria cutanea tarda: In porphyria cutanea tarda, an uroporphyrinogen</p><p>decarboxylase deficiency exists which metabolises uroporphyrinogen to</p><p>coproporphyrinogen. The objective of metabolic alkalisation is to prevent back diffusion of coproporphyrin through renal tubuli so that the coproporphyrin clearance will increase. As a consequence of the increased coproporphyrinogen excretion, the synthesis of coproporphyrinogen from uroporphyrinogen is believed to increase and is consequently accompanied by a decrease in circulating uroporphyrin. Urinary pH levels</p><p>should be adjusted to range between 7.2 - 7.5.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Citrate undergoes almost complete metabolic breakdown. Only 1.5% to 2% of the original administered dose appears unchanged in the urine.</p><p>Intake of 10 g of potassium sodium hydrogen citrate yields approximately 36 mmol of citrate; this is equivalent to less than 2% of the daily turnover of citrate involved in energy metabolism within the body.</p><p>After a one-day intake of potassium sodium hydrogen citrate, the equivalent amounts of sodium and potassium are quantitatively excreted via the kidneys within 24 - 48 hours.</p><p>During long-term administration, daily excretion of sodium and potassium is in equilibrium with the daily intake.</p><p>No significant changes in blood gases or in serum electrolytes have been observed.</p><p>This indicates that by virtue of renal regulation of alkalinization the acid-base balance of the body remains intact and that, provided renal function is adequate, any possibility of accumulation of sodium or potassium can be excluded.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>According to the results obtained from investigations in animals, potassium sodium hydrogen citrate (6:6:3:5) has no toxicological potential in the prescribed dosage.</p><p>Chronic tests in rats revealed that oral doses between 1 g / kg and less than 3 g / kg of bodyweight were safe.</p><p>Toxicological tests on reproduction in rats and rabbits at 2 g / kg of bodyweight revealed no teratogenic or embryotoxic/fetotoxic effects.</p><p>When observing the contraindications and notes, no cancerogenic and mutagenic effects are to be expected for the intended mode and duration of use.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;Aroma: Lemon oil; Coloring agent: Yellow Orange S (E 110).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                 3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;Do not store above 30&deg;C</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Original pack containing 280 g of granules.</p><p>The pack also contain indicator paper and control calendars.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Viatris Healthcare GmbH
Lütticher Straße 5
53842 Troisdorf
Germany

Fax: (06172) 888-27 40
Email: medinfo@medapharma.de

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jan 2024
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>